SCHEMBL7786089

SCHEMBL7786089

COc1ccc2c(c1OC)C(=O)c1ccccc1-2

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.87
SMN1; SMN2 Q16637 4/20 0.87
NPC1 O15118 2/20 0.87
MAPT P10636 7/20 0.67
ALDH1A1 P00352 7/20 0.67
MEN1 O00255 5/20 0.67
KMT2A Q03164 5/20 0.67
KDM4E B2RXH2 4/20 0.67
TDP1 Q9NUW8 2/20 0.67
USP2 O75604 2/20 0.67
DUSP3 P51452 1/20 0.67
POLB P06746 3/20 0.56
THRB P10828 2/20 0.56
MAPK1 P28482 2/20 0.56
ADORA2A P29274 2/20 0.56
FGB P02675 1/20 0.56
PPARG P37231 1/20 0.56
NCOA2 Q15596 1/20 0.56
NCOA1 Q15788 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL496978 0.93 RAB9A (1.00) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL4700188 0.87 RAB9A (0.71) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL9181274 0.87 RAB9A (0.65) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL7970824 0.82 RAB9A (0.65) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL3862633 0.81 RAB9A (0.58) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL28792529 0.81 RAB9A (0.63) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
1,4-Dimethoxyanthraquinone SCHEMBL3417221 0.81 MAPT (1.00) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL9264626 0.79 MAPT (0.74) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL12253692 0.79 RAB9A (0.76) RAB9ASMN1; SMN2NPC1MAPTALDH1A1
SCHEMBL29126288 0.78 MAPT (0.66) RAB9ASMN1; SMN2NPC1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109700791-A Hongmaoxinjian is preparing the application in anti-benign prostatic hyperplasis drug 西安交通大学 2019-05-03 CN disclosed
EP-0906268-B1 ALKYLOXYAMINO SUBSTITUTED FLUORENONES AND THEIR USE AS PROTEIN KINASE C INHIBITORS AVENTIS PHARMA INC (US) 2001-11-28 EP disclosed
US-6194439-B1 ANTICANCER AGENT PFIZER INC. 2001-02-27 US disclosed
EP-0906268-A1 ALKYLOXYAMINO SUBSTITUTED FLUORENONES AND THEIR USE AS PROTEIN KINASE C INHIBITORS HOECHST MARION ROUSSEL, INC. (US) 1999-04-07 EP disclosed
WO-1997045397-A1 ALKYLOXYAMINO SUBSTITUTED FLUORENONES AND THEIR USE AS PROTEIN KINASE C INHIBITORS HOECHST MARION ROUSSEL, INC. (US) 1997-12-04 WO disclosed
EP-0586608-A1 TRICYCLIC POLYHYDROXYLIC TYROSINE KINASE INHIBITORS PFIZER INC. (US) 1994-03-16 EP disclosed
WO-1992021660-A1 TRICYCLIC POLYHYDROXYLIC TYROSINE KINASE INHIBITORS PFIZER, INC. (US) 1992-12-10 WO disclosed